Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...
Recursion Pharmaceuticals expanded its collaboration with Citeline to integrate real world data into its AI enabled ClinTech Platform. The partnership is aimed at refining clinical trial design and ...
In March 2026, Citeline announced an expanded strategic partnership with Recursion Pharmaceuticals to integrate Citeline's real-world data and evidence into Recursion’s tech-enabled drug discovery and ...
17d
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion (NASDAQ: RXRX), a leading tech-bio company decoding biology ...
In just a few short months, Marathon has minted a highly quotable line: “Escape will make me God.” It’s also, according to ...
Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki Goodman, M.D., will become Recursion’s Chief Medical Officer ...
As artificial intelligence continues to evolve at a rapid pace, industry leaders say its future will hinge not just on ...
Generic formats like JSON or XML are easier to version than forms. However, they were not originally intended to be ...
According to market consultancy Frost & Sullivan, the global AI-enabled pharmaceutical R&D market is projected to grow from ...
Holding signs and banners reading Stop the AI Race and Don’t Build Skynet, the protesters marched through the city and gave ...
Meta's new hyperagent framework breaks the AI "maintenance wall," allowing systems to autonomously rewrite their own logic ...
AI is making it easier to design chips and optimize software for different silicon. Some startups envision a revolution in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results